First study to assess multiple ascending doses (30 mg and 120 mg)
- 2 Doses of CBD given twice per day for three consecutive days. Evaluated these parameters: (1) Pharmacokinetic profile, (2) Anti-inflammatory properties (e.g. immunologic assays), and (3) Bid dosage and steady state blood levels
- Bid dosing achieved steady state blood levels of CBD